Cancer 2024

Orestis Ioannidis speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Open abdomen and negative pressure wound therapy for acute peritonitis especially in the presence of anastomoses and ostomies

Orestis Ioannidis Aristotle University of Thessaloniki, Greece

Acute peritonitis is a relatively common intra-abdominal infection that a general surgeon will have to manage many times in his surgical carrier. Us [....] Read More

Mirza Muhammad Faran Ashraf Baig speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Recent Advances of Magnetic Gold Hybrids and Nanocomposites, and Their Potential Biological Applications

Mirza Muhammad Faran Ashraf Baig The Hong Kong University of Science and Technology, China

Magnetic gold nanoparticles (mGNP) have become a great interest of research for nanomaterial scientists because of their significant magnetic and pl [....] Read More

Kakali Bhadra speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

Novel derivative carboline compounds: Synthesis, binding and anti-proliferative effects on human cancer cell lines

Kakali Bhadra University of Kalyani, India

Research in upcoming field of molecular medicine and gene therapy are constantly utilizing DNA as target macromolecules. Hence, various classes of n [....] Read More

Michael B Yaffe speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation

TBA

Michael B Yaffe Massachusetts Institute of Technology, USA

[....] Read More

Jianhua Luo speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation (In-Person)

Serum fusion transcript markers to predict liver cancer and monitor the treatment impact through machine learning

Jianhua Luo University of Pittsburgh, USA

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies for human. Early diagnosis of HCC is crucial in reducing the mortality of the [....] Read More

Johnathan R Whetstine speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation

TBA

Johnathan R Whetstine Fox Chase Cancer Center, USA

[....] Read More

Salvador Martinez speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (In-Person)

Induced immunosuppression by brain pericytes helps in glioma genesis and progression.

Salvador Martinez Miguel Hernandez University, Spain

Direct interaction between perivascular cells, termed pericytes (PC), and glioblastoma multiforme (GBM) cells is essential for inducing changes in the [....] Read More

Je Hyun Yoon speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (In-Person)

Metabolic regulation by noncoding RNAs

Je Hyun Yoon University of OklahomaUniversity of Oklahoma, USA

Accelerated glycolysis is the main metabolic change observed in cancer, but the underlying molecular mechanisms and their role in cancer progression r [....] Read More

Rachna Chhachhi speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation (In-Person)

Oral Cancer And Treatments That Increase Survival Rate

Rachna Chhachhi Cancer, Nutrition & Mental Health Therapist, India

The incidence of different kinds of Oral Cancers has increased by 34% in the decade. The different types of oral cancers that exist are Lymphoma minor [....] Read More

Yan Peng speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

TBA

Yan Peng The University of Texas Southwestern Medical Center, USA

TBA [....] Read More

Nitin T TELANG speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation

Colon Cancer Stem Cell Models for Drug Discovery

Nitin T TELANG Palindrome Liaisons Consultants, USA

Pharmacological chemotherapeutic agents represent mainstream treatment options for colon cancer. Conventional and targeted therapeutics are associated [....] Read More

Thomas J Vogl speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Keynote Presentation

TBA

Thomas J Vogl University of Frankfurt, Germany

[....] Read More

Eleni Petsalaki speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation

A novel mechanism for chromatin bridge sensing by the abscission checkpoint in human cells

Eleni Petsalaki University of Crete, Greece

Chromatin bridges are DNA strings that link anaphase poles or daughter nuclei and are associated with carcinogenesis. DNA bridges occur from the sep [....] Read More

Anne Catherine HEUSKIN speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (Virtual)

Exploring UHDR Irradiation Parameters and FLASH Effect Occurrence on C. elegans and Tumor Spheroids

Anne Catherine HEUSKIN University of Namur, Belgium

UHDR irradiations show healthy tissue sparing effect known as the FLASH effect. Since 2014, the FLASH effect has been investigated worldwide to unders [....] Read More

Klepinin Aleksandr speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (Virtual)

TBA

Klepinin Aleksandr University of Salford, UK

Updating... [....] Read More

Martin Porebski speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Poster Presentation (Virtual)

Genetic, Immune and Metabolic Endpoints as Biomarkers of Immune Checkpoint Therapy Response

Martin Porebski Wake Forest School of Medicine, USA

The development of immunotherapies represents a significant advance within clinical oncology, but its efficacy is confined to a subset of patients, an [....] Read More

Maria Borrell speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (Virtual)

PCSK9 is a cholesterol lowering agent with a role in cancer progression

Maria Borrell Sant Pau Institute for Biomedical Research, Spain

There are numerous evidences that Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) inhibitors combat cancer. These cholesterol lowering agents, togeth [....] Read More

Huiling Li speaker at 2nd International Conference on Innovations and Advances in Cancer Research and Treatment
Oral Presentation (Virtual)

AI-Assisted 3D Printing Transvaginal Template Guidance for Interstitial Brachytherapy in Patients with gynecologic malignancy

Huiling Li Fujian Medical University, China

Background: The three-dimensional (3D) interstitial Brachytherapy (BT) can enhance the efficacy of bulky cervical cancer treatment. BT technology guid [....] Read More